AngioDynamics to Present at the Canaccord Genuity Growth Conference
July 23 2019 - 4:01PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that Jim
Clemmer, President and Chief Executive Officer, will present at the
39th Annual Canaccord Genuity Growth Conference at 10:30 a.m. ET on
Wednesday, August 7, 2019 in Boston, MA.
A live webcast of the presentation will be accessible through
the “Investors” section of the Company’s website at
www.angiodynamics.com and will be available for replay following
the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, peripheral vascular disease, and
oncology. AngioDynamics’ diverse product lines include
market-leading ablation systems, vascular access products,
angiographic products and accessories, drainage products,
thrombolytic products, and venous products. For more information,
visit www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190723005822/en/
Investor Contact: AngioDynamics, Inc. Michael C. Greiner,
Executive Vice President & CFO (518) 795-1821
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Sep 2023 to Sep 2024